Unlikely to cause harm — often a labeling or packaging issue.
Labeling: Incorrect or Missing Lot and/or Expiration Date
| Brand name | ESCITALOPRAM |
| Generic name | ESCITSLOPRAM |
| Active ingredient(s) | ESCITALOPRAM OXALATE |
| Distributed by / for | Lupin Pharmaceuticals, Baltimore, MD, 21202 |
| NDC | 68180-136-01 |
| Full product label | Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01 |
| Recalling firm | Lupin Limited |
| Distribution | Nationwide |
| Quantity | 3,192 bottles (319,200 tablets) |
| Recall initiated | 2016-03-24 |
| Report date | 2016-09-28 |
| Recall completed | 2017-03-15 |
| Recall number | D-1516-201 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Verna, Salcette, Goa India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗